Additive value of 18FDG-PET/CT to positive 131I whole body scan in recurrent differentiated thyroid cancer patients with potential influence on treatment strategy: single Egyptian center experience
Abstract Background Years ago the utility of of18F-fluorodeoxyglucose-positron emission tomography/computerized tomography (18FDG-PET/CT) in differentiated thyroid cancer was confined mainly to cases with elevated serum thyroglobulin and negative 131I whole body scan. In this study, we try to assess...
Main Authors: | Heba M. Abdelhamed, Amira E. Mohammed, Mona S. Fattahalla, HebatAllah Askar |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2022-01-01
|
Series: | The Egyptian Journal of Radiology and Nuclear Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43055-021-00692-x |
Similar Items
-
A Three-Domain Scoring System to Customize the Risk of Relapse of Differentiated Thyroid Carcinoma
by: Arnoldo Piccardo, et al.
Published: (2021-08-01) -
Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a 131I-SPECT/CT study
by: Angela Spanu, et al.
Published: (2020-03-01) -
Impact of 18F-FDG PET/CT on treatment of patients with differentiated thyroid carcinoma, negative 131I whole body scan and elevated serum thyroglobulin
by: Raef Boktor, et al.
Published: (2022-01-01) -
Absorbed Dose Evaluation in Radioiodine Therapy with Different Approaches
by: Stefania Mazzaglia, et al.
Published: (2019-08-01) -
The Diagnostic Usefulness of <sup>131</sup>I-SPECT/CT at Both Radioiodine Ablation and during Long-Term Follow-Up in Patients Thyroidectomized for Differentiated Thyroid Carcinoma: Analysis of Tissue Risk Factors Ascertained at Surgery and Correlated with Metastasis Appearance
by: Angela Spanu, et al.
Published: (2021-08-01)